Hims & Hers Completes Eucalyptus Acquisition, Expands to Germany, Canada, Australia
HIMS•Hims & Hers Health has completed its acquisition of Eucalyptus, including Juniper, Pilot, Kin and Software, to establish the world’s largest consumer health platform. The deal expands its footprint into Australia with over 500,000 users and strengthens weight-management and generic semaglutide offerings in Germany and Canada.
1. Acquisition Overview
On June 2, 2026, Hims & Hers Health finalized its purchase of Eucalyptus, acquiring the Juniper, Pilot, Kin and Software divisions to unify its consumer health offerings under one global platform.
2. Market Expansion in Key Regions
The transaction secures entry into Australia—where Juniper has served over 500,000 customers—and deepens operations in Germany’s weight-management market while enhancing Canadian access to generic semaglutide.
3. Platform Scale and Customer Impact
Combining Eucalyptus’ clinically backed weight-management care with Hims & Hers’ technology and data infrastructure aims to accelerate user acquisition and cross-sell services across a broader patient base.
4. Strategic and Financial Implications
The acquisition bolsters Hims & Hers’ clinical and technological capabilities, positioning it for revenue growth and potential cost synergies, though financing terms and impact on leverage remain undisclosed.
